PTC THERAPEUTICS, INC. — Director's Dealing 2015

Jan 17, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2015-01-15

Reporting Person: Hirawat Claudia de Oliveira Ribeiro (President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-01-15	Common Stock	M	2396	$10.85	Acquired	41396	Direct
2015-01-15	Common Stock	S	2149	$57.19	Disposed	39247	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-01-15	Stock Option (right to buy)	$10.85	M	2396	Disposed	2023-05-15	Common Stock (2396)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	194	Indirect

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan.

F2: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $56.66 to $57.61 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F3: Pursuant to the Separation and General Release Agreement dated December 16, 2014 between the Reporting Person and the Issuer (the Separation Agreement), the remaining options vest on January 16, 2015

F4: Pursuant to the Separation Agreement, the remaining options will expire on January 31, 2016.